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Chronic heart failure (CHF) is a syndrome characterized by reduced cardiac output (CO) unable to meet metabolic 
demands of active tissues. The reduced (HFrEF) or preserved ejection fraction (HFpEF) identifies the systolic and 
diastolic HF respectively. Evidence has demonstrated that metabolic reflex coming from skeletal muscle evokes 
cardiovascular adjustments during exercise. Hemodynamic response to metaboreflex activation is defined as a rise 
in mean arterial blood pressure (MAP) achieved by an increase in systemic vascular resistance (SVR) and/or by 
an increase in CO. In healthy individuals, the metaboreflex‐induced increase in blood pressure mainly depends on 
CO increment. The aim of the present study was to assess cardiovascular adjustments during metaboreflex 
activation in both kinds of CHF patients compared to a control group of healthy individuals (CTL). 
Methods 
Three groups of age‐matched subjects were studied: 1) 12 males patients diagnosed with HFrEF; 2) 8 males 
patients with diagnosed HFpEF; 3) 12 healthy individuals (CTL). All participants underwent a general medical 
examination, an incremental exercise test on a cycle ergometer to test their physical capacity, and a metaboreflex 
activation protocol consisting in a post exercise muscle ischemia (PEMI) and in a control exercise recovery (CER) 
session. All hemodynamic parameters were measured non‐invasively by impedance cardiography. 
Results 
Statistical analysis showed no differences in heart rate (HR) response among groups. Stroke volume (SV) and CO 
responses were not significantly different between the two groups of HF patients. SV and CO responses were 
significantly higher in the CTL than in both the HFrEF and the HFpEF group. SVR response was significantly 
higher in the HFrEF as compared to the CTL group, while no differences existed between the CTL and the 
HFpEF. MAP response to PEMI was not different among groups. Ventricular Filling Rate (VFR, a measure of 
diastolic function) response was significantly higher in CTL group in comparison with the HFrEF and the HFpEF 
groups. Ventricular Emptying Rate (VER, a measure of systolic function) response was significantly higher in 
CTL group as compared to the two groups of patients. 
Conclusion 
Notwithstanding the described reduced capacity to enhance CO, the MAP response was not different among 
groups. This indicates that the possibility to reach an effective MAP pressure was unaltered in both groups of 
patients with CHF. This was likely the consequence of an exaggerated vasoconstriction due to a sympathetic 
overdrive in both groups of CHF patients. These findings are in good agreement with previous research dealing 
with HFrEF and HFpEF, which demonstrated the blood pressure rise during the metaboreflex is mainly achieved 
by a vasoconstriction‐mediated rather than a flow‐mediated mechanism. Of note the SVR increase was more 
accentuated in the HFrEF than in the HFpEF group, and this phenomenon suggests that the cardiovascular 
impairment was more pronounced in the former than in the latter group of patients. 
https://faseb.onlinelibrary.wiley.com/doi/abs/10.1096/fasebj.2020.34.s1.03246 
